BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25262883)

  • 1. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital.
    Wang M; Wang W; Abeywardane A; Adikarama M; McLornan D; Raj K; de Lavallade H; Devereux S; Mufti GJ; Pagliuca A; Potter VT; Mijovic A
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):60-6. PubMed ID: 25262883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
    Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience.
    Lv W; Qu H; Wu M; Fan Z; Huang F; Xu N; Xuan L; Lin R; Zhao K; Sun J; Lai Y; Xu Y; Liu Q
    Cancer Med; 2019 Nov; 8(15):6549-6558. PubMed ID: 31502764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
    Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
    Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal immune hemolytic anemia following allogeneic stem cell transplantation: report of 2 cases and review of literature.
    Rovira J; Cid J; Gutiérrez-García G; Pereira A; Fernández-Avilés F; Rosiñol L; Martínez C; Carreras E; Urbano A; Rovira M; Lozano M
    Transfus Med Rev; 2013 Jul; 27(3):166-70. PubMed ID: 23562007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
    Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
    Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.
    O'Brien TA; Eastlund T; Peters C; Neglia JP; Defor T; Ramsay NK; Scott Baker K
    Br J Haematol; 2004 Oct; 127(1):67-75. PubMed ID: 15384979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children.
    Chang TY; Jaing TH; Wen YC; Huang IA; Chen SH; Tsay PK
    Medicine (Baltimore); 2016 Nov; 95(46):e5396. PubMed ID: 27861376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes of autoimmune hemolytic anemia after pediatric allogeneic stem cell transplant.
    Hillier K; Harris EM; Berbert L; Pai SY; Grace RF
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29410. PubMed ID: 34709706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in thalassemia major].
    Zhang ZM; Lai YR; Li QC; Luo L; Liu RR; Shi LL; Liu LJ
    Zhonghua Xue Ye Xue Za Zhi; 2018 Nov; 39(11):908-911. PubMed ID: 30486586
    [No Abstract]   [Full Text] [Related]  

  • 14. Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation.
    Schuetz C; Hoenig M; Moshous D; Weinstock C; Castelle M; Bendavid M; Shimano K; Tolbert V; Schulz AS; Dvorak CC
    Blood Adv; 2018 Oct; 2(19):2550-2553. PubMed ID: 30291113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.
    Kako S; Kanda Y; Oshima K; Nishimoto N; Sato H; Watanabe T; Hosoya N; Motokura T; Miyakoshi S; Taniguchi S; Kamijo A; Takahashi K; Chiba S; Kurokawa M
    Am J Hematol; 2008 Mar; 83(3):247-9. PubMed ID: 17918251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.
    Koo J; Giller RH; Quinones R; McKinney CM; Verneris MR; Knight-Perry J
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28591. PubMed ID: 32658382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH).
    González-Vicent M; Sanz J; Fuster JL; Cid J; de Heredia CD; Morillo D; Fernández JM; Pascual A; Badell I; Serrano D; Fox L; de la Serna J; Benito A; Couselo JM; Molina B; Díaz MÁ; Sanz MÁ
    Transfus Med Rev; 2018 Mar; ():. PubMed ID: 29573905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.